- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT03350945
Application of Carbon Nanoparticles in Laparoscopic Colorectal Surgery
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Colorectal cancer is among the most commonly diagnosed cancer in both men and women . Increasing studies have been focused on the causes and therapies of this disease in order to improve the prognosis. In recent decades, laparoscopy has been commonly used in both colorectal and gastric surgery due to the benefit of minimal invasive technology progression . Its comparable safety and effectiveness have been proved in many studies. The advantages of minimal invasive surgery such as faster recovery, less bleeding and less pain, have also been admitted by numerous surgeons . However, the accomplishment of operation procedures mainly depend on subjective experiences. Even skilled surgeons can be impeded in operation due to the deficiency of tactile sense . As a result, accurate intra-operative localization of tumor would be a tough task if it was invisible on the serosal surface or difficult to approach, such as small or flat neoplasms, tumor confined to the mucosa and submucosa and endoscopically resected polyps which required additional surgery . At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing. All of these methods have their advantages but also some unavoidable limitations, such as localization error and problems in the assessment of incision margin using preoperative clip placement, unsatisfactory operation exposure after intraoperative endoscopy, ink spillage or failure in finding lesions with dye endoscopic injection et al. Usually surgeons choose different methods according to the objective conditions such as the ability to perform endoscopy or the availability of suitable tattooing material.
Apart from the precise localization of tumor, adequate lymph node dissection is another crucial point in colorectal operation. According to AJCC recommendation and NCCN guideline, the number of lymph nodes, which has been proved of prognostic and therapeutic importance, is clearly defined in colorectal cancer to make sure of the accurate pathological staging. Previous studies have found that the number of lymph nodes evaluated after surgical resection was positively associated with the survival of patients. Besides Total Mesorectal Excision (TME) and D3 lymph node clearance, which are standards in colorectal surgery over decades of research and accumulated data, the harvest of lymph nodes is still associated with pathological doctors' experience and pathological examination skills. However, population-based data suggest that lymph node evaluation is not adequate in the majority of patients . Some micro lymph nodes, especially with diameter less than 5 mm, are more easily missed in specimen process while rate of metastasis is comparably higher in these lymph nodes. As a result, clinicians are trying to find a lymph node tracer to help improve the amount of lymph node harvest as well as the rate of micro-metastasis in lymph node.
Carbon nanoparticle has been used as a lymph node tracer for decades. As a lymphatic vessel specific dye material, there is no doubt in its effect on lymph node mapping. In recent years, surgeons have applied this tracer widely in breast and thyroid operations for sentinel lymph node mapping to determine dissection extent. The effectiveness and accuracy of this method has been verified in thyroid and breast surgery while there is rare study focused on its application in colorectal surgery. The application of tattooing material, such as methylene blue, India ink and nano-materials in tumor localization has also attracted attentions of clinicians. In our study, three groups based on different tumor localization means are compared on short-term benefits, cost-effectiveness and lymph node clearance in order to choose the best approach to locate tumor and validate lymph node staining effect of carbon nanoparticles.
Tipo de estudio
Inscripción (Anticipado)
Fase
- No aplica
Contactos y Ubicaciones
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Pathologically diagnosed as colorectal benign tumor or tumor with TNM staging I-III (including patients need further surgery after endoscopic treatment), Be able to tolerate laparoscopic radical resection With normal hepatic and renal function No history of abdominal surgery
Exclusion Criteria:
- Patients with distant metastasis, poor compliance, prior abdominal surgery Emergency case with obstruction or perforation Have received neoadjuvant chemotherapy or radiotherapy Patients diagnosed as familial adenomatous polyposis (FAP), Inflammatory bowel disease such as ulcerative colitis and Crohn's disease
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Triple
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Comparador activo: Device:Titanium Clips
Device: Tumor localization.
Preoperative endoscopic localization with titanium clips
|
At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
|
|
Comparador activo: Device:Intra-operative Endoscopy
Device: Tumor localization.
During the laparoscopic surgery,tumor is localized using intra-operative endoscopy detection.
|
At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
|
|
Experimental: Device:Carbon Nanoparticles
Device: Tumor localization.
During the laparoscopic surgery,tumor is localized using carbon nanoparticles.
|
At present, three dominant methods can be available to locate tumor: preoperative endoscopic clip placement, intraoperative endoscopy and endoscopic tattooing
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Tumor localization time
Periodo de tiempo: within 1 month
|
From abdominal exploration to tumor localization
|
within 1 month
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
survival data 1
Periodo de tiempo: within 5 year
|
overall survival
|
within 5 year
|
|
survival data 2
Periodo de tiempo: within 5 year
|
disease free survival
|
within 5 year
|
|
Post-operative complication rates
Periodo de tiempo: within 6 month
|
According to the records in hospital
|
within 6 month
|
|
Distal edge distance of specimen
Periodo de tiempo: within 2 weeks
|
measured by two pathologists separately
|
within 2 weeks
|
|
LN number dissected
Periodo de tiempo: within 2-3 weeks
|
measured by two pathologists separately
|
within 2-3 weeks
|
|
Length of stay
Periodo de tiempo: within a year
|
According to the record in hospital
|
within a year
|
|
Total operation time
Periodo de tiempo: within 1 week
|
Measured according to operation record
|
within 1 week
|
|
Blood loss
Periodo de tiempo: within 1 week
|
Measured according to operation record
|
within 1 week
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Silla de estudio: Minhua Zheng, Ruijin Hospital
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Anticipado)
Finalización primaria (Anticipado)
Finalización del estudio (Anticipado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- LAiguo
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Tumor colorrectal
-
Avelos Therapeutics Inc.ReclutamientoTumor solido | Cáncer de tumor sólido | Tumor Sólido, Adulto | Tumor Sólido, No Especificado, Adulto | Tumor Sólido | Tumor sólido en etapa avanzada | Tumores sólidos refractarios a la terapia estándarCorea, república de
-
Sorrento Therapeutics, Inc.RetiradoTumor solido | Tumor sólido en recaída | Tumor refractario
-
Aadi Bioscience, Inc.ReclutamientoTumor sólido avanzado | Tumor | Tumor SólidoEstados Unidos
-
Memorial Sloan Kettering Cancer CenterReclutamientoTumor solido | Tumor Sólido, Adulto | Tumor Sólido, No Especificado, AdultoEstados Unidos
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterReclutamientoTumor solido | Tumor Sólido, Adulto | Tumor Sólido, No Especificado, AdultoEstados Unidos, Puerto Rico
-
Memorial Sloan Kettering Cancer CenterLincoln Medical and Mental Health CenterReclutamientoTumor solido | Tumor Sólido, Adulto | Tumor Sólido, No Especificado, AdultoEstados Unidos, Puerto Rico
-
RemeGen Co., Ltd.TerminadoTumor sólido metastásico | Tumor sólido localmente avanzado | Tumor sólido irresecableAustralia
-
Memorial Sloan Kettering Cancer CenterReclutamientoTumor solido | Tumor Sólido, AdultoEstados Unidos
-
National Health Research Institutes, TaiwanNational Cheng-Kung University HospitalReclutamiento
-
Elpiscience Biopharma, Ltd.Shanghai Junshi Bioscience Co., Ltd.TerminadoNeoplasias | Tumor solido | Tumor malignoPorcelana
Ensayos clínicos sobre Device: tumor localization
-
Lahore General HospitalTerminadoNeoplasias de la vejiga urinaria | Cáncer de vejiga sin invasión muscularPakistán
-
Emory UniversityTerminadoCáncer de mama | Neoplasias de mama | Tumores de mama | Neoplasias De Mama | Cáncer de mama | Cáncer de mama | Carcinoma mamario humanoEstados Unidos
-
European Institute of OncologyReclutamiento
-
Shanghai General Hospital, Shanghai Jiao Tong University...Desconocido
-
Institut Claudius RegaudReclutamientoCáncer de mama metastásico | Cáncer de mama tempranoFrancia
-
Aga Khan UniversityDesconocidoEnfermedades o condiciones musculoesqueléticasPakistán
-
Mansoura UniversityDesconocidoNeoplasia de vejiga urinariaEgipto
-
Karl Landsteiner University of Health SciencesReclutamientoAdenocarcinoma de pulmón | Tumores voluminosos | Cáncer irresecableAustria
-
Tang-Du HospitalReclutamientoGrasa Parda y Músculo Metabólico | Diagnóstico diferencialPorcelana
-
University Hospital, ToursInstitut National de la Santé Et de la Recherche Médicale, FranceTerminadoTumor Cerebral PrimarioFrancia